Meanwhile, Angelique Cotes, a member of the South African Medical Association, said symptoms from the new mutation appeared to be mild “compared to those treated before”.
She added that these symptoms range from feeling tired to muscle pain, and she added, “What we have noticed so far, is that those who have contracted it, do not suffer from a loss of their senses of smell and taste, and they also have a slight cough.”
She indicated that some of those infected with the new mutation of the emerging corona virus are subject to treatment in their homes, which means that their condition is not dangerous.
Scientists are still waiting to obtain sufficient data on who has been infected to determine the severity of the new mutation, and whether it is actually able to undermine the efficacy of vaccines against infection.
Earlier on Tuesday, the British Prime Minister ruled out, Boris JohnsonAnother closure was imposed in Britain due to the Omicron mutant, describing the matter as “unlikely”, while indicating that there is close monitoring of the developments of the emerging Corona virus.
Johnson announced, during a press conference in London, plans to give the third and booster dose of the vaccine against Corona, to all adults over the age of 18 in Britain, starting next January.
The British Prime Minister indicated that 400 members of the British army will help in the process of distributing vaccines against the Corona virus, amid great fears that the situation will worsen due to the recently detected “Omicron” mutant.
Meanwhile, Oxford University said, today, Tuesday, that there is no evidence that currently available vaccines against the Corona virus cannot prevent infection with the “Omicron” mutant.
The university added that it is ready to develop an updated version of its anti-Covid-19 vaccine, “AstraZeneca”, if necessary, noting that it has the appropriate means to develop the vaccine.
The University of Oxford indicated that there is limited data on Omicron so far, and that it will carefully evaluate the impact of the new mutation on the vaccine.
For his part, the president of the pharmaceutical company Moderna said that it is not likely that the vaccines against Covid-19 will be as effective with the mutated Omicron strain of the Corona virus as it is with the Delta strain.